Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
SNDX:NASDAQ
Syndax Pharmaceuticals Inc
$20.23
-1.56%
(-0.32) 1D
$20.23
0.00% (0.00)
After hours
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNDX...
Open
$20.43
High
$20.93
Low
$20.16
Mkt. cap
1.79B
Avg. vol.
1.67M
Volume
1.84M
52-wk high
$25.59
52-wk low
$8.58
EPS
-$3.29
Beta
0.42
Shares outstanding
88.61M
No. of employees
298
News stories
From sources across the web
About Syndax Pharmaceuticals Inc
CEO-
Employees298
Founded2005
Headquarters-
SectorBiotechnology
Websitesyndax.com
Last report
Apr 30, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.48 / -$0.60
+19.45%beat
Revenue / Est. (USD)
64.86M / 69.74M
-6.99%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
37.96M
45.87M
68.73M
64.86M
Cost of goods sold
63.51M
58.38M
81.35M
2.63M
Cost of revenue
63.51M
58.38M
81.35M
2.63M
Research and development expenses
-
-
-
58.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.80M
44.92M
49.93M
37.59M
Operating expense
43.80M
44.92M
49.93M
96.43M
Total operating expenses
107.31M
103.30M
131.28M
99.07M
Operating income
-69.35M
-57.43M
-62.55M
-34.20M
Other non operating income
-586.00K
-275.00K
-201.00K
-186.00K
EBT including unusual items
-71.85M
-60.72M
-68.01M
-42.67M
EBT excluding unusual items
-71.85M
-60.72M
-68.01M
-42.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-71.85M
-60.72M
-68.01M
-42.67M
Net profit margin
-189.28%
-132.36%
-98.96%
-65.79%
Earnings per share
-0.83
-0.70
-0.78
-0.48
Interest and investment income
5.95M
5.27M
4.33M
3.56M
Interest expense
-7.86M
-8.28M
-9.59M
-11.85M
Net interest expenses
-1.91M
-3.01M
-5.26M
-8.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
-69.35M
-57.42M
-62.54M
-34.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more